1. Home
  2. VANI vs RMI Comparison

VANI vs RMI Comparison

Compare VANI & RMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
  • RMI
  • Stock Information
  • Founded
  • VANI 1998
  • RMI 2018
  • Country
  • VANI United States
  • RMI United States
  • Employees
  • VANI N/A
  • RMI N/A
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RMI Finance/Investors Services
  • Sector
  • VANI Health Care
  • RMI Finance
  • Exchange
  • VANI Nasdaq
  • RMI Nasdaq
  • Market Cap
  • VANI 81.2M
  • RMI 94.0M
  • IPO Year
  • VANI 2014
  • RMI N/A
  • Fundamental
  • Price
  • VANI $1.61
  • RMI $14.71
  • Analyst Decision
  • VANI Strong Buy
  • RMI
  • Analyst Count
  • VANI 1
  • RMI 0
  • Target Price
  • VANI $4.00
  • RMI N/A
  • AVG Volume (30 Days)
  • VANI 484.1K
  • RMI 17.4K
  • Earning Date
  • VANI 11-13-2025
  • RMI 01-01-0001
  • Dividend Yield
  • VANI N/A
  • RMI 7.28%
  • EPS Growth
  • VANI N/A
  • RMI N/A
  • EPS
  • VANI N/A
  • RMI N/A
  • Revenue
  • VANI N/A
  • RMI N/A
  • Revenue This Year
  • VANI N/A
  • RMI N/A
  • Revenue Next Year
  • VANI N/A
  • RMI N/A
  • P/E Ratio
  • VANI N/A
  • RMI N/A
  • Revenue Growth
  • VANI N/A
  • RMI N/A
  • 52 Week Low
  • VANI $0.91
  • RMI $13.05
  • 52 Week High
  • VANI $1.92
  • RMI $17.37
  • Technical
  • Relative Strength Index (RSI)
  • VANI 53.84
  • RMI 62.73
  • Support Level
  • VANI $1.59
  • RMI $14.40
  • Resistance Level
  • VANI $1.81
  • RMI $14.83
  • Average True Range (ATR)
  • VANI 0.15
  • RMI 0.14
  • MACD
  • VANI 0.00
  • RMI -0.01
  • Stochastic Oscillator
  • VANI 49.18
  • RMI 76.47

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

About RMI RiverNorth Opportunistic Municipal Income Fund Inc.

RiverNorth Opportunistic Municipal Income Fund, Inc. is a diversified, closed-end management investment company. Its investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.

Share on Social Networks: